MHRA/EMC SmPCs for liraglutide and semaglutide) Common Incretin Drugs Used in the UK Several incretin-based medications are currently licensed and available through the NHS in the UK, falling into two main categories: GLP-1 receptor agonists (including dual GIP/GLP-1 receptor agonists) and DPP-4 inhibitors
Depressed individuals consistently show reduced BDNF levels, particularly in the hippocampus and prefrontal cortex
Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G et al (2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in idiopathic intracranial hypertension
Managing weight effectively during this period becomes a critical component of long-term health optimization
GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone involved in signaling fullness and controlling blood sugar levels